Importantly, the systematic analysis of 109 ITIM-bearing receptors in humans (63 typically expressed in B cells) indicated that ALL characterized by the Philadelphia chromosome (Ph+) showed a stronger expression of LAIR1, CD300A, and PECAM1, among others. Here, CD300A is linked to acute lymphoblastic leukemia.